Benoît Boeuf

Benoît Boeuf

Auto-generated profile, based on publicly available information

Benoît Boeuf

CHU Clermont-Ferrand, Service Réanimation Pédiatrique et Périnatalogie, F-63000 Clermont-Ferrand, France

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2003 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
BBBenoit Boeuf
Benoit Boeuf
VPVéronique Poirier
Véronique Poirier
FGFrance Gauvin
France Gauvin
AGAnne-Marie Guerguerian
Anne-Marie Guerguerian
CRChantal Roy
Chantal Roy
JLJacques Lacroix
Jacques Lacroix

1 August 2009 in Journal of Clinical Virology
Verified
Journal Article
Closed access
CHCécile Henquell
Cécile Henquell
BBBenoît Bœuf
Benoît Bœuf
AMAudrey Mirand
Audrey Mirand
CBCatherine Bacher
Catherine Bacher
OTOusmane Traore
Ousmane Traore
HPHélène Peigue-Lafeuille
Hélène Peigue-Lafeuille

19 April 2021 in Metabolites
Verified
Journal Article
Open access
PDF file
BLBERNARD Lise
BERNARD Lise
YBYassine Bouattour
Yassine Bouattour
MMMorgane Masse
Morgane Masse
BBBenoît Boeuf
Benoît Boeuf
BDBertrand Décaudin
Bertrand Décaudin
FGfor the ARMED Study Group
for the ARMED Study Group
Care management of newborns in the neonatal intensive care unit (NICU) requires numerous PVC (PolyVinyl Chloride) medical devices (MD) containing plasticizers that can migrate and contaminate the patient. We measured the magnitude of neonates’ exposure to plasticizers (di-ethylhexylphthalate (DEHP) and alternatives) in relation to urinary concentrations of their metabolites. Plasticizers’ exposure was evaluated (1) by calculating the amounts of plasticizers prone to be released from each MD used for care management, and (2) by measuring the patients’ urinary levels of each plasticizers’ metabolites. 104 neonates were enrolled. They were exposed to di-isononylphthalate (DINP), especially via transfusion and infusion MD, and to DEHP via ECMO (Extra Corporeal Membrane Oxygenation) and respiratory assistance MD. Mean exposure doses exceeded the derived no-effect level of DINP and DEHP by a 10-fold and a 1000-fold factor. No PVC MD were plasticized with di-isononylcyclohexane-1,2-dicarboxylate (DINCH). High urinary concentrations of DEHP metabolites were directly correlated with DEHP exposure through ECMO MD. Urinary concentrations of DINP metabolites in transfused patients were also high. DINCH metabolites were found in urine, suggesting another route of exposure. Neonates in NICU are considerably exposed to plasticizers, with magnitudes varying with the type of MD used. The high exposure to DEHP and DINP leads to a risk of their metabolites’ toxicity.

1 July 2022 in Annales Pharmaceutiques Françaises
Verified
Journal Article
Closed access
PPP. Plaidy
P. Plaidy
PCPhilip Chennell
Philip Chennell
IWI. Wamen
I. Wamen
LGL. Germon
L. Germon
BBB. Boeuf
B. Boeuf
BLBERNARD Lise
BERNARD Lise

3 September 2021 in Metabolites
Verified
Journal Article
Open access
PDF file
BLBERNARD Lise
BERNARD Lise
YBYassine Bouattour
Yassine Bouattour
MMMorgane Masse
Morgane Masse
BBBenoît Boeuf
Benoît Boeuf
BDBertrand Décaudin
Bertrand Décaudin
FGfor the ARMED Study Group
for the ARMED Study Group
The comments written by R. Otter et al.